REFERENCES
- Kresken M, Hafner D, Mittermayer H, et al. Prevalence of fruoroquinolone resistance in Europe. Infection 1994; 22 (suppl 2): S90-7.
- Voutsinas D, Mavroudis Th, Avlamis A, Giamarellou H. In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobials. J Antimicrob Chemother 1989; 24 (suppl A): 143-7.
- Kanellakopoulou K, Giamarellou H, Papadothomakos P, et al. Meropenem versus imipenem/cilastatin in the treat-ment of intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 1993; 12: 449–53.
- Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupezynski Y. Bactericidal activity of meropen-em against Pseudomonas aeruginosa. J Antimicrob Chemother 1989; 24 (suppl A): 169-74.
- Livermore DM, Yang Y. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms. J Antimicrob Chemother 1989; 24 (suppl A): 149-59.
- Trias J, Nikaido H. Outer membrane protein D2 cat-alyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990; 34: 52–7.
- Ferrara A, Grassi G, Grassi FA, Piccioni PD, Gialdroni Grassi G. Bactericidal activity of meropenem and interactions with other antibiotics. J Antimicrob Chemother 1989; 24 (suppl A): 239-50.
- Margaret BS, Drusano GL, Standiford HC. Emergence of resistance to carbapenem antibiotics in Pseudomonas aerug-inosa. J Antimicrob Chemother 1989; 24 (suppl A): 161-7.
- Sumita Y, Fukasawa M. Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associ-ated with suppression of outer membrane protein D2 synthe-sis. Antimicrob Agents Chemother 1993; 37: 2743–6.
- Livermore DM. Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992; 36: 2046–8.
- Satake S, Yoneyama H, Nakae T. Role of Omp D2 and chromosomal beta-lactamase in carbapenem resistance in clin-ical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 1991; 28: 199–207.
- Yang Y, Livermore DM. Interactions of meropenem with class I chromosomal β-lactamases. J Antimicrob Chemother 1989; 24 (suppl A): 207-17.